XML 51 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholder's Investments (Tables)
12 Months Ended
Jul. 31, 2018
Equity [Abstract]  
Schedule of Capital Stock
Information as to the Company’s capital stock at July 31, 2018 and 2017 is as follows:
 
 
July 31, 2018
 
July 31, 2017
 
 
Shares
Authorized
 
Shares
Issued
 
(thousands)
Amount
 
Shares
Authorized
 
Shares
Issued
 
(thousands)
Amount
Preferred Stock, $.01 par value
 
5,000,000

 
 
 
 
 
5,000,000

 
 
 
 
Cumulative Preferred Stock:
6% Cumulative
 
5,000

 
 
 
 
 
5,000

 
 
 
 
1972 Series
 
10,000

 
 
 
 
 
10,000

 
 
 
 
1979 Series
 
30,000

 
 
 
 
 
30,000

 
 
 
 
Common Stock, $.01 par value: Class A Nonvoting
 
100,000,000

 
51,261,487

 
$
513

 
100,000,000

 
51,261,487

 
$
513

Class B Voting
 
10,000,000

 
3,538,628

 
35

 
10,000,000

 
3,538,628

 
35

 
 
 
 
 
 
$
548

 
 
 
 
 
$
548

Schedule of Other Activity in Stockholders' Investment
The following is a summary of other activity in stockholders’ investment for the fiscal years ended July 31, 2018, 2017, and 2016:
 
 
Deferred Compensation
 
Shares Held in Rabbi Trust, at cost
 
Total
Balances at July 31, 2015
 
$
5,684

 
$
(8,748
)
 
$
(3,064
)
Shares at July 31, 2015
 
252,261

 
362,025

 
 
Sale of shares at cost
 
$
(1,238
)
 
$
1,278

 
$
40

Purchase of shares at cost
 
178

 
(1,017
)
 
(839
)
Balances at July 31, 2016
 
$
4,624

 
$
(8,487
)
 
$
(3,863
)
Shares at July 31, 2016
 
201,418

 
347,081

 
 
Sale of shares at cost
 
$
(1,247
)
 
$
1,288

 
$
41

Purchase of shares at cost
 
315

 
(925
)
 
(610
)
Effect of plan amendment
 
4,432

 

 
4,432

Balances at July 31, 2017
 
$
8,124

 
$
(8,124
)
 
$

Shares at July 31, 2017
 
314,082

 
314,082

 
 
Sale of shares at cost
 
$
(977
)
 
$
977

 
$

Purchase of shares at cost
 
1,075

 
(1,075
)
 

Balances at July 31, 2018
 
$
8,222

 
$
(8,222
)
 
$

Shares at July 31, 2018
 
299,916

 
299,916

 
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
Black-Scholes Option Valuation Assumptions
 
2018
 
2017
 
2016
Expected term (in years)
 
6.07

 
6.11

 
6.11

Expected volatility
 
28.19
%
 
29.55
%
 
29.95
%
Expected dividend yield
 
2.72
%
 
2.70
%
 
2.59
%
Risk-free interest rate
 
1.96
%
 
1.26
%
 
1.64
%
Weighted-average market value of underlying stock at grant date
 
$
36.85

 
$
35.14

 
$
20.02

Weighted-average exercise price
 
$
36.85

 
$
35.14

 
$
20.02

Weighted-average fair value of options granted during the period
 
$
7.96

 
$
7.56

 
$
4.58

Summary of Stock Option Activity under Company's Share-Based Compensation Plans
for the fiscal year ended July 31, 2018:
 
 
Option Price
 
Options Outstanding
 
Weighted Average Exercise Price
Balance as of July 31, 2017
 
$
19.96

$38.83
 
2,879,801

 
$
27.40

Options granted
 
36.85

36.85
 
364,046

 
36.85

Options exercised
 
19.96

38.31
 
(622,916
)
 
28.84

Options cancelled
 
19.96

38.31
 
(116,298
)
 
31.42

Balance as of July 31, 2018
 
$
19.96

$38.83
 
2,504,633

 
$
28.23

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table summarizes information about stock options outstanding at July 31, 2018:
 
 
Options Outstanding
 
Options Outstanding and Exercisable
Range of Exercise Prices
 
Number of  Shares
Outstanding at
July 31, 2018
 
Weighted  Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Shares
Exercisable
at July 31,
2018
 
Weighted  Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
$19.96 - $26.99
 
846,353

 
6.7
 
$
20.84

 
611,735

 
6.5
 
$
21.16

$27.00 - $32.99
 
978,233

 
3.3
 
29.24

 
977,506

 
3.3
 
29.24

$33.00 - $38.83
 
680,047

 
8.4
 
35.97

 
132,988

 
7.2
 
35.13

Total
 
2,504,633

 
5.8
 
$
28.23

 
1,722,229

 
4.7
 
$
26.82

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following tables summarize the RSU and restricted share activity for the fiscal year ended July 31, 2018:
Time-Based RSUs and Restricted Shares
 
Shares
 
Weighted Average Grant Date
 Fair Value
Balance as of July 31, 2017
 
517,108

 
$
25.61

New grants
 
94,457

 
36.80

Vested
 
(219,389
)
 
24.76

Forfeited
 
(49,320
)
 
26.94

Balance as of July 31, 2018
 
342,856

 
$
29.05


The time-based RSUs granted during the fiscal year ended July 31, 2017, had a weighted-average grant-date fair value of $35.15. The total fair value of time-based RSU's vested during the years ended July 31, 2018 and 2017, was $8,237 and $6,512, respectively.
Performance-Based RSUs
 
Shares
 
Weighted Average Grant Date
Fair Value
Balance as of July 31, 2017
 
58,206

 
$
32.03

New grants
 
56,290

 
33.12

Vested
 

 

Forfeited
 
(6,399
)
 
32.57

Balance as of July 31, 2018
 
108,097

 
$
32.57

The performance-based RSUs granted during the year ended July 31, 2017, had a weighted-average grant-date fair value of $32.03. The aggregate intrinsic value of unvested time-based and performance-based RSU's outstanding at July 31, 2018 and 2017, and expected to vest, was $17,249 and $19,100, respectively.